137 related articles for article (PubMed ID: 33992797)
1. Bruceine A induces cell growth inhibition and apoptosis through PFKFB4/GSK3β signaling in pancreatic cancer.
Zhang P; Tao W; Lu C; Fan L; Jiang Q; Yang C; Shang E; Cheng H; Che C; Duan J; Zhao M
Pharmacol Res; 2021 Jul; 169():105658. PubMed ID: 33992797
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the mitochondrial pathway in bruceine D-induced apoptosis in Capan-2 human pancreatic adenocarcinoma cells.
Liu L; Lin ZX; Leung PS; Chen LH; Zhao M; Liang J
Int J Mol Med; 2012 Jul; 30(1):93-9. PubMed ID: 22552257
[TBL] [Abstract][Full Text] [Related]
3. Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth.
Chesney J; Clark J; Klarer AC; Imbert-Fernandez Y; Lane AN; Telang S
Oncotarget; 2014 Aug; 5(16):6670-86. PubMed ID: 25115398
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis induced by bruceine D in human non‑small‑cell lung cancer cells involves mitochondrial ROS‑mediated death signaling.
Xie JH; Lai ZQ; Zheng XH; Xian YF; Li Q; Ip SP; Xie YL; Chen JN; Su ZR; Lin ZX; Yang XB
Int J Mol Med; 2019 Dec; 44(6):2015-2026. PubMed ID: 31638181
[TBL] [Abstract][Full Text] [Related]
5. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells.
Ros S; Flöter J; Kaymak I; Da Costa C; Houddane A; Dubuis S; Griffiths B; Mitter R; Walz S; Blake S; Behrens A; Brindle KM; Zamboni N; Rider MH; Schulze A
Oncogene; 2017 Jun; 36(23):3287-3299. PubMed ID: 28092678
[TBL] [Abstract][Full Text] [Related]
6. Bruceine D inhibits tumor growth and stem cell-like traits of osteosarcoma through inhibition of STAT3 signaling pathway.
Wang S; Hu H; Zhong B; Shi D; Qing X; Cheng C; Deng X; Zhang Z; Shao Z
Cancer Med; 2019 Dec; 8(17):7345-7358. PubMed ID: 31631559
[TBL] [Abstract][Full Text] [Related]
7. PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance.
Feng C; Li Y; Li K; Lyu Y; Zhu W; Jiang H; Wen H
J Exp Clin Cancer Res; 2021 Sep; 40(1):308. PubMed ID: 34593007
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of efficacy of bruceine A, a natural quassinoid compound extracted from a medicinal plant, Brucea javanica, for canine babesiosis.
Nakao R; Mizukami C; Kawamura Y; Subeki ; Bawm S; Yamasaki M; Maede Y; Matsuura H; Nabeta K; Nonaka N; Oku Y; Katakura K
J Vet Med Sci; 2009 Jan; 71(1):33-41. PubMed ID: 19194074
[TBL] [Abstract][Full Text] [Related]
9. A novel P38α MAPK activator Bruceine A exhibits potent anti-pancreatic cancer activity.
Lu C; Fan L; Zhang PF; Tao WW; Yang CB; Shang EX; Chen FY; Che CT; Cheng HB; Duan JA; Zhao M
Comput Struct Biotechnol J; 2021; 19():3437-3450. PubMed ID: 34194669
[TBL] [Abstract][Full Text] [Related]
10. Nortriptyline induces mitochondria and death receptor-mediated apoptosis in bladder cancer cells and inhibits bladder tumor growth in vivo.
Yuan SY; Cheng CL; Ho HC; Wang SS; Chiu KY; Su CK; Ou YC; Lin CC
Eur J Pharmacol; 2015 Aug; 761():309-20. PubMed ID: 26086857
[TBL] [Abstract][Full Text] [Related]
11. E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner.
Zhang L; Liu Z; Dong Y; Kong L
Life Sci; 2021 Jul; 276():119412. PubMed ID: 33774025
[TBL] [Abstract][Full Text] [Related]
12. Loss of PFKFB4 induces cell cycle arrest and glucose metabolism inhibition by inactivating MEK/ERK/c-Myc pathway in cervical cancer cells.
Wu Y; Zhang L; Bao Y; Wan B; Shu D; Luo T; He Z
J Obstet Gynaecol; 2022 Aug; 42(6):2399-2405. PubMed ID: 35659173
[TBL] [Abstract][Full Text] [Related]
13. Romidepsin induces G2/M phase arrest via Erk/cdc25C/cdc2/cyclinB pathway and apoptosis induction through JNK/c-Jun/caspase3 pathway in hepatocellular carcinoma cells.
Sun WJ; Huang H; He B; Hu DH; Li PH; Yu YJ; Zhou XH; Lv Z; Zhou L; Hu TY; Yao ZC; Lu MD; Shen X; Zheng ZQ
Biochem Pharmacol; 2017 Mar; 127():90-100. PubMed ID: 28012958
[TBL] [Abstract][Full Text] [Related]
14. Bruceine D induces apoptosis in pancreatic adenocarcinoma cell line PANC-1 through the activation of p38-mitogen activated protein kinase.
Lau ST; Lin ZX; Liao Y; Zhao M; Cheng CH; Leung PS
Cancer Lett; 2009 Aug; 281(1):42-52. PubMed ID: 19286308
[TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.
Shimasaki T; Ishigaki Y; Nakamura Y; Takata T; Nakaya N; Nakajima H; Sato I; Zhao X; Kitano A; Kawakami K; Tanaka T; Takegami T; Tomosugi N; Minamoto T; Motoo Y
J Gastroenterol; 2012 Mar; 47(3):321-33. PubMed ID: 22041920
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
17. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
18. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 acts as a protein kinase to regulate glioblastoma progression by activating the AKT/forkhead box O1 pathway.
Zhao K; Yu C; Luo J; Huang M; Wen Q; Zhao N
Acta Biochim Pol; 2022 Feb; 69(1):165-172. PubMed ID: 35143148
[TBL] [Abstract][Full Text] [Related]
19. Targeting the sugar metabolism of tumors with a first-in-class 6-phosphofructo-2-kinase (PFKFB4) inhibitor.
Chesney J; Clark J; Lanceta L; Trent JO; Telang S
Oncotarget; 2015 Jul; 6(20):18001-11. PubMed ID: 26221874
[TBL] [Abstract][Full Text] [Related]
20. Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer.
Dasgupta S; Rajapakshe K; Zhu B; Nikolai BC; Yi P; Putluri N; Choi JM; Jung SY; Coarfa C; Westbrook TF; Zhang XH; Foulds CE; Tsai SY; Tsai MJ; O'Malley BW
Nature; 2018 Apr; 556(7700):249-254. PubMed ID: 29615789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
